Microglia As conTroller of braIn metaboLism During Aging
This project aims to investigate how microglia, via the Trem2 gene, influence hypothalamic metabolism and energy homeostasis, with potential implications for treating immunometabolic dysfunction.
Projectdetails
Introduction
Microglia represent the main brain residential immune cells. In the last years, evidence emerged that, besides representing the first line of defense against pathogenic insults, microglia are also centrally involved in physiological functions essential for correct CNS development and function.
Role of Microglia
Microglia, in a spatially and temporally controlled manner, influence:
- Neuronal apoptosis
- Neurogenesis
- Myelin formation
- Synapse homeostasis, including removing supernumerary synapses during development
These widely heterogeneous roles are supported by distinct subtypes—or states—of microglia, present in different regions of the brain and at different times during CNS development.
Key Gene: Trem2
In the last years, Triggering Receptor Expressed on Myeloid cells 2 (Trem2) emerged as a key gene which controls the microglial metabolic state, in addition to directing synapse elimination and shaping functional brain connectivity.
Project Proposal
In the present project, I propose that microglia, via Trem2, direct the genetic signature of specific subgroups of brain cells, shifting them toward specific metabolic and developmental patterns. I hypothesize that this mechanism is key for the control of metabolism in the hypothalamus, where the neuronal contingents orchestrating systemic energy homeostasis reside.
Methodology
By using a combination of:
- Transcriptomics
- Multiplex protein expression analysis
- Cell-based imaging methods
I will determine which subsets of microglia cooperate within hypothalamic centers and will define the underlying mechanisms.
Impact of the Study
I will also assess whether defects in this orchestrated crosstalk affect the central regulation of energy and glucose homeostasis during aging. Data from this study will provide comprehensive knowledge of microglia functions in shaping hypothalamic complexity and endocrine output.
Additionally, they will offer a targeting potential for new therapeutic strategies that could reverse immunometabolic dysfunction by modulation of hypothalamic microglial function.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 2.500.000 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 31-12-2027 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- HUMANITAS MIRASOLE SPApenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
TREM2 MICROglia ENGENEering for treating dementiaS (TREM2MICROENGINES)TREM2MICROENGINES aims to restore TREM2 expression in microglia of Alzheimer's and Nasu–Hakola disease patients to enhance neuroinflammation response and reduce amyloid-β accumulation. | ERC Proof of... | € 150.000 | 2022 | Details |
Deciphering the microglia-neuron interactions in human Alzheimer's diseaseThis project aims to elucidate how human microglia contribute to neuronal toxicity in Alzheimer's disease using a pioneering xenograft model to explore their interactions and secretome. | ERC Starting... | € 1.500.000 | 2023 | Details |
Studying the metabolism and function of myeloid dendritic cells and neutrophils in distinct tissues in health and agingThis project aims to uncover how metabolic adaptations of dendritic cells and neutrophils in various tissues influence their immune functions and dysfunction in aging, paving the way for targeted therapies. | ERC Starting... | € 1.499.500 | 2024 | Details |
Microglia engineering and replacement to treat brain diseaseThe ReplaceMi project aims to develop a translatable strategy for replacing dysfunctional microglia with healthy progenitors to treat neurodegenerative diseases through innovative technologies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
HUNTING GHOST NEURONS IN THE NEUROENDOCRINE HYPOTHALAMUSThe Ghostbuster project aims to identify and understand 'Ghost' neurons in the hypothalamus that exhibit plasticity in adult life, potentially revolutionizing treatments for neuroendocrine disorders. | ERC Consolid... | € 2.000.000 | 2024 | Details |
TREM2 MICROglia ENGENEering for treating dementiaS (TREM2MICROENGINES)
TREM2MICROENGINES aims to restore TREM2 expression in microglia of Alzheimer's and Nasu–Hakola disease patients to enhance neuroinflammation response and reduce amyloid-β accumulation.
Deciphering the microglia-neuron interactions in human Alzheimer's disease
This project aims to elucidate how human microglia contribute to neuronal toxicity in Alzheimer's disease using a pioneering xenograft model to explore their interactions and secretome.
Studying the metabolism and function of myeloid dendritic cells and neutrophils in distinct tissues in health and aging
This project aims to uncover how metabolic adaptations of dendritic cells and neutrophils in various tissues influence their immune functions and dysfunction in aging, paving the way for targeted therapies.
Microglia engineering and replacement to treat brain disease
The ReplaceMi project aims to develop a translatable strategy for replacing dysfunctional microglia with healthy progenitors to treat neurodegenerative diseases through innovative technologies.
HUNTING GHOST NEURONS IN THE NEUROENDOCRINE HYPOTHALAMUS
The Ghostbuster project aims to identify and understand 'Ghost' neurons in the hypothalamus that exhibit plasticity in adult life, potentially revolutionizing treatments for neuroendocrine disorders.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Towards the clinical implementation of TREM2 Microglia Engineering for treating DementiaSTREM2MEDS aims to transition a novel gene therapy for Alzheimer’s and Nasu-Hakola Diseases from preclinical validation to a Phase I clinical trial, targeting TREM2 dysfunction in microglia. | EIC Transition | € 2.499.721 | 2024 | Details |
Towards the clinical implementation of TREM2 Microglia Engineering for treating DementiaS
TREM2MEDS aims to transition a novel gene therapy for Alzheimer’s and Nasu-Hakola Diseases from preclinical validation to a Phase I clinical trial, targeting TREM2 dysfunction in microglia.